Interpace Diagnostics Presents New Data from Over 3,400 Patients Tested with ThyGenX®/ThyraMIR®

VICTORIA, British Columbia, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” ...

Interpace Diagnostics Presents New Data from Over 3,400 Patients Tested with ThyGenX®/ThyraMIR®

VICTORIA, British Columbia, Oct. 18, 2017 (GLOBE NEWSWIRE) -- Interpace Diagnostics Group, Inc. (NASDAQ:IDXG) (“Interpace” ...

MicroRNA Research Tools, Diagnostics and Therapeutics Markets, 2014-2021

Dublin, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The "MicroRNA Research Tools, Diagnostics and Therapeutics: ...

MicroRNA Research Tools, Diagnostics and Therapeutics Markets, 2014-2021

Dublin, Oct. 18, 2017 (GLOBE NEWSWIRE) -- The "MicroRNA Research Tools, Diagnostics and Therapeutics: ...

GEORGE L. BLACKBURN, MD, PHD – NUTRITION AND METABOLISM SYMPOSIUM

National Harbor, MD, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Thousands of leading researchers and ...

GEORGE L. BLACKBURN, MD, PHD – NUTRITION AND METABOLISM SYMPOSIUM

National Harbor, MD, Oct. 10, 2017 (GLOBE NEWSWIRE) -- Thousands of leading researchers and ...

Ascendis Pharma A/S Announces Proposed Public Offering of ADSs

COPENHAGEN, Denmark, Sept. 26, 2017 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a clinical ...

[sam_pro id=0_12 codes="true"]
[sam_pro id=0_6 codes="false"]